WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow A correction has been published
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (79)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tessitore, A.
Right arrow Articles by Mattay, V. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tessitore, A.
Right arrow Articles by Mattay, V. S.

 Previous Article  |  Next Article 

The Journal of Neuroscience, October 15, 2002, 22(20):9099-9103

Dopamine Modulates the Response of the Human Amygdala: A Study in Parkinson's Disease

Alessandro Tessitore1, Ahmad R. Hariri1, Francesco Fera1, William G. Smith1, Thomas N. Chase2, Thomas M. Hyde1, Daniel R. Weinberger1, and Venkata S. Mattay1

1 Clinical Brain Disorders Branch, National Institute of Mental Health, and 2 Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892

In addition to classic motor signs and symptoms, Parkinson's disease (PD) is characterized by neuropsychological and emotional deficits, including a blunted emotional response. In the present study, we explored both the neural basis of abnormal emotional behavior in PD and the physiological effects of dopaminergic therapy on the response of the amygdala, a central structure in emotion processing. PD patients and matched normal controls (NCs) were studied with blood oxygenation level-dependent functional magnetic resonance imaging during a paradigm that involved perceptual processing of fearful stimuli. PD patients were studied twice, once during a relatively hypodopaminergic state (i.e., >= 12 hr after their last dose of dopamimetic treatment) and again during a dopamine-replete state. The imaging data revealed a robust bilateral amygdala response in NCs that was absent in PD patients during the hypodopaminergic state. Dopamine repletion partially restored this response in PD patients. Our results demonstrate an abnormal amygdala response in PD that may underlie the emotional deficits accompanying the disease. Furthermore, consistent with findings in experimental animal paradigms, our results provide in vivo evidence of the role of dopamine in modulating the response of the amygdala to sensory information in human subjects.

Key words: Parkinson's disease; dopamine; amygdala; modulating emotions; BOLD fMRI; depression


Copyright © 2002 Society for Neuroscience  0270-6474/02/22209099-05$05.00/0


This article has been cited by other articles:


Home page
PediatricsHome page
L. Strathearn, J. Li, P. Fonagy, and P. R. Montague
What's in a Smile? Maternal Brain Responses to Infant Facial Cues
Pediatrics, July 1, 2008; 122(1): 40 - 51.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
K. L. Phan, M. Angstadt, J. Golden, I. Onyewuenyi, A. Popovska, and H. de Wit
Cannabinoid Modulation of Amygdala Reactivity to Social Signals of Threat in Humans
J. Neurosci., March 5, 2008; 28(10): 2313 - 2319.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
E. M. Drabant, A. R. Hariri, A. Meyer-Lindenberg, K. E. Munoz, V. S. Mattay, B. S. Kolachana, M. F. Egan, and D. R. Weinberger
Catechol O-methyltransferase Val158Met Genotype and Neural Mechanisms Related to Affective Arousal and Regulation
Arch Gen Psychiatry, December 1, 2006; 63(12): 1396 - 1406.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
D. Bowers, K. Miller, A. Mikos, L. Kirsch-Darrow, U. Springer, H. Fernandez, K. Foote, and M. Okun
Startling facts about emotion in Parkinson's disease: blunted reactivity to aversive stimuli
Brain, December 1, 2006; 129(12): 3356 - 3365.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
A. Suzuki, T. Hoshino, K. Shigemasu, and M. Kawamura
Disgust-specific impairment of facial expression recognition in Parkinson's disease
Brain, March 1, 2006; 129(3): 707 - 717.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
A. R. Hariri, E. M. Drabant, K. E. Munoz, B. S. Kolachana, V. S. Mattay, M. F. Egan, and D. R. Weinberger
A Susceptibility Gene for Affective Disorders and the Response of the Human Amygdala
Arch Gen Psychiatry, February 1, 2005; 62(2): 146 - 152.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. N. Smolka, G. Schumann, J. Wrase, S. M. Grusser, H. Flor, K. Mann, D. F. Braus, D. Goldman, C. Buchel, and A. Heinz
Catechol-O-Methyltransferase val158met Genotype Affects Processing of Emotional Stimuli in the Amygdala and Prefrontal Cortex
J. Neurosci., January 26, 2005; 25(4): 836 - 842.
[Abstract] [Full Text] [PDF]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-